Sobre este pódcast
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
35 episodios · science
Few & Far Between: How Biotech Gets Built
Último episodioEpisode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc.
Sobre este pódcast
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Episodios recientes
- Episode 72: Joel White, Owner, Marketcap Consulting22 jun · 53 min
- Episode 71: Chris O'Brien, Former Biorasi CEO and Current CEO of Rancho Biosciences12 may · 43 min
- Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School17 mar · 1 h 02 min
- Video Episode 68: Sinan Gölhan, CEO at GelTech Labs27 ene · 44 min
- Video Episode 67: Aoife Brennan, President and CEO of Climb Bio7 ene · 1 h 12 min
- Episode 66: Mark Abelson, Founder of Ora Clinical16 dic 2025 · 43 min
- Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience24 nov 2025 · 1 h 07 min
- Video Episode 64 - Professor Justin Stebbing11 nov 2025 · 48 min
- Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences28 oct 2025 · 1 h 01 min
- Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology22 oct 2025 · 44 min
podlinkr.com/es/few-and-far-between-how-biotech-gets-built
Para un cartel o una diapositiva.